Creo Medical Group PLC

AIM:CREO Stock Report

Mkt Cap: UK£35.3m

Creo Medical Group Future Growth

How is Creo Medical Group forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE

52.3%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

AIM:CREO - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202554-3021
12/31/202441-12-10-71
12/31/202333-17-17-164
6/30/202226-28-37-29N/A
3/31/202226-26-34-28N/A
12/31/202125-25-32-26N/A
9/30/202124-23-26-22N/A
6/30/202122-21-19-19N/A
3/31/202116-21-18-18N/A
12/31/20209-20-17-16N/A
9/30/20205-19-17-16N/A
6/30/20200-17-17-16N/A
3/31/20200-17-15-14N/A
12/31/20190-16-13-12N/A
6/30/20190-13-14-13N/A
3/31/20190-12-12-11N/A
12/31/2018N/A-10-10-10N/A
12/31/20170-8-10-9N/A
9/30/20170-8-9-8N/A
6/30/2017N/A-8-7-7N/A
6/30/20161-5-5-5N/A
2/29/20161-3N/A-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CREO is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CREO is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CREO is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CREO's revenue (24.1% per year) is forecast to grow faster than the UK market (4.2% per year).

High Growth Revenue: CREO's revenue (24.1% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if CREO's Return on Equity is forecast to be high in 3 years time

Discover growth companies